目前已经应用的一项技术叫做植入前基因诊断(PGD)。
A technique already in use is called preimplantation genetic diagnosis (PGD).
它显示了单细胞测序技术在胚胎植入前基因诊断的临床实践潜力。
It shows the potential of single-cell sequencing technology in preimplantation genetic diagnosis clinical practices.
之后，通过“移植前基因诊断”，选取了没有病态基因且与孩子组织类型匹配的胚胎。
Then, using a process called pre-implantation genetic diagnosis (PGD), they selected one that was free of the unwanted gene and also matched the boy's tissue type.
同样的精卵结合方式很可能应用于“移植前基因诊断”，给那些患有其他基因疾病的人，包括白血病和珠蛋白生成障碍性贫血患者带来希望。
The same ready acceptance is likely to apply to PGD, which offers hope to sufferers of other genetic disorders, including leukaemia4 and thalas-saemia.
为避免将TSC遗传给下一代，TSC患者可用胚胎植入前遗传学诊断（PGD）技术对体外受精（IVF）形成的胚胎进行TSC基因突变的检测。
People with TSC can consider using pre-implantation genetic diagnosis (PGD) to detect a TSC gene change in embryos created through in vitro fertilization (IVF).
目的研究干血斑(DBS)样本用于人类免疫缺陷病毒1型(HIV - 1)感染前病毒DNA基因诊断的可行性。
Objective To assess the feasibility of detection of HIV-1 proviral DNA on Dried Blood Spot (DBS) samples by nested-PCR assay.
结论建立的单卵裂球PCR技术是稳定可靠的，可以用于单基因病的着床前遗传学诊断。
Conclusion: Single blastomere PCR is stable and reliable, and it can be used for preimplantation genetic diagnosis.
胚胎移植前遗传学诊断（PGD）起源于90年代初，是怀孕的夫妇防止胎儿受到异常基因或染色体影响的一种有效措施。
PGD was first performed in the early 1990's as a way for couples to prevent the pregnancy of a child with genetic disease.
胚胎移植前遗传学诊断（PGD）起源于90年代初，是怀孕的夫妇防止胎儿受到异常基因或染色体影响的一种有效措施。
PGD was first performed in the early 1990's as a way for couples to prevent the pregnancy of a child with genetic disease.
应用推荐